We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Recently, the Supreme Court denied Apotex's leave application for leave to appeal to the Supreme Court of Canada in respect of Apotex's case seeking damages for alleged delays due to a proceeding brought by Merck under the Patented Medicines (Notice of Compliance Regulations) ("NOC Regulations"
